Navigation Links
Isis Reports Financial Results and Highlights for First Quarter of 2008
Date:5/12/2008

bis was also awarded up to approximately $2.8 million in government

contracts and grants.

-- Regulus Therapeutics

o Regulus, Isis' joint venture formed in September 2007, is focused on

developing microRNA therapeutics, as a new approach to target the

pathways of human disease. Last month, Regulus entered into a

strategic alliance with GSK that could provide up

to nearly $600 million to Regulus to develop microRNA-targeted

therapeutics to treat inflammatory disease.

-- Regulus received a $20 million upfront payment, including a

$15 million option fee and payment for a $5 million note that

will convert into Regulus common stock under certain

circumstances.

-- The alliance provides GSK with an option to license drug

candidates directed at four different inflammatory disease

microRNA targets.

-- Regulus will receive up to $144.5 million in development,

regulatory and sales milestone payments for each

microRNA-targeted drug discovered and developed as part of the

collaboration.

-- Regulus will also receive tiered royalties up to double digits

on sales of drugs resulting from the alliance.

Conference Call

At 08:30 a.m. Eastern Time today, May 12, Isis will conduct a live webcast conference call to discuss this earnings release and related activities. Interested parties may access the webcast at http://www.isispharm.com, or listen to the call by dialing 877-548-7906. A webcast replay will be available for a limited time at the same address.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The C
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to announce a ... Q-Suite is their flagship contact center ACD system for Asterisk-based call centers . ... shows the script components to the agent only when wanted, and allows for validation ...
(Date:7/31/2015)... Mirada, CA (PRWEB) , ... July 31, 2015 ... ... Southern California, has announced plans to release a newly redesigned website at Healthpointe.net. ... navigation and enhanced user experience. , The redesign serves to provide smoother ...
(Date:7/31/2015)... , ... July 31, 2015 , ... According to ... a direct result of heroin use and eventual overdoses. Thricefold deaths have held steady ... get a handle on the Sarasota heroin epidemic, which was spurred by the crackdown ...
(Date:7/31/2015)... Metamora, Michigan (PRWEB) , ... July 31, 2015 ... ... 100th baby at Beaumont Hospital's Karmanos Center for Natural Birth . ... mothers looking for a safe natural childbirth experience. With nurses and caregivers that ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to announce that ... in a mobile application format available on iPhones, iPads, and Android smartphones and ...
Breaking Medicine News(10 mins):Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:Healthpointe Announces Newly Redesigned Website 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3
... remove key cue to safety; group seeks legislative help ... be nearly silent, hybrid cars pose a serious threat of ... the American Council of the Blind, which is pushing the ... this danger. , "Traditionally, people who are blind or visually ...
... in Obesity and Weight Management ... ... Inc., the,pioneer in applying advanced technology to emulate a health coaching,session ... management,behavioral health, and medication adherence, is launching HealthMedia(R),Overcoming(TM) Binge Eating. This ...
... PITTSBURGH, July 21 Mylan Inc. (NYSE: ... Crookshank as vice president -,Investor Relations and as ... to Chief Financial Officer Edward J. Borkowski, Crookshank ... as for the,development and direction of activities that ...
... HUNTSVILLE, Ala., July 21 Health,Care Systems, Inc. ... the market leader in medication reconciliation solutions, has ... of the largest,locally owned not-for-profit hospitals in the ... serves as a teaching facility for The,University of ...
... for action from ICANN, US-based domain ... ... an,online pharmacy verification service, and KnujOn.com, an Internet spam and,criminality watchdog, ... illicit sale of anabolic steroids., Steroid abuse is part of ...
... future alternative to bypass surgery, researchers say , , FRIDAY, ... grown in mice the kind of functioning heart blood ... One ultimate goal is to replace some heart surgery ... in the body, providing a system of blood vessels ...
Cached Medicine News:Health News:Hybrid Cars Pose Risk to Blind, Visually Impaired 2Health News:HealthMedia Launches First-Ever Binge Eating Campaign and Intervention to Take on Nation's Top Eating Disorder 2Health News:HealthMedia Launches First-Ever Binge Eating Campaign and Intervention to Take on Nation's Top Eating Disorder 3Health News:HealthMedia Launches First-Ever Binge Eating Campaign and Intervention to Take on Nation's Top Eating Disorder 4Health News:Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations 2Health News:Huntsville Hospital Signs With Health Care Systems, Inc. for Automated Medication Reconciliation Services 2Health News:Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids 2Health News:Heart Blood Vessels Grown in the Lab 2
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... 31, 2015 According to a ... Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold ... Global Analysis & Forecast to 2019", published by MarketsandMarkets, ... $911.1 Million 2014 and is estimated to grow to ... 9.4% from 2014 to 2019. Browse ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Market 2011-2021 - what are the ... http://www.reportlinker.com/p0578544/Lyophilisation-for-Pharmaceuticals-Technology-and-Services-Market-2011-2021---what-are-the-revenue-prospects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic What are ...
... Inc. (NASDAQ: CALP ) today reported its financial ... quarter revenue increased to $38.3 million, or 32%, from $29.1 ... excludes the effects of acquisitions, divestitures and currency changes, grew ... a year-to-date basis).  Caliper reported a second quarter net loss ...
Cached Medicine Technology:Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 2Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 3Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 4Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 5Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 6Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 7Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 8Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 9Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 10Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 11Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 12Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects? 13Caliper Life Sciences Reports Second Quarter 2011 Results 2Caliper Life Sciences Reports Second Quarter 2011 Results 3Caliper Life Sciences Reports Second Quarter 2011 Results 4Caliper Life Sciences Reports Second Quarter 2011 Results 5Caliper Life Sciences Reports Second Quarter 2011 Results 6Caliper Life Sciences Reports Second Quarter 2011 Results 7Caliper Life Sciences Reports Second Quarter 2011 Results 8Caliper Life Sciences Reports Second Quarter 2011 Results 9Caliper Life Sciences Reports Second Quarter 2011 Results 10
The Vivid e delivers everything you need in a compact echo system, like complete cardiovascular functionality, a comprehensive cardiac measurement and analysis package, and full shared service capabi...
BonePlast is a fast resorbing, osteoconductive bone void filler. By delivering a high dose of calcium to the operative site, BonePlast helps build new bone during the healing process. Packaged in a c...
... The patented telescoping plate ... an anterior plate and vertebral ... design eliminates the need for ... generous amount of bone graft ...
"Small" redefined for Holter recorders!...
Medicine Products: